Medical research

Weakened malaria parasites form basis of new vaccine strategy

Using live but weakened malaria parasites as the basis of a vaccine represents a potentially encouraging anti-malaria strategy, according to results of follow-up animal studies performed after the conclusion of a recent clinical ...

Diseases, Conditions, Syndromes

Hidden malaria life cycle discovered in the spleen

Groundbreaking studies published today in the New England Journal of Medicine and PLOS Medicine have found large numbers of malaria parasites hiding in the human spleen where they actively multiply in a previously unrecognized ...

Diseases, Conditions, Syndromes

Pyramax receives positive opinion from the EMA

Pyramax, a fixed-dose combination of pyronaridine and artesunate, becomes the first antimalarial to be granted a positive scientific opinion from the European Medicines Agency (EMA) under Article 58. This once daily, 3-day ...

Diseases, Conditions, Syndromes

A two-pronged approach to target critical malaria protein

A protein that plays a critical role in helping malaria parasites infect red blood cells—known as apical membrane protein 1 (AMA1)—has been found to bind to more than one receptor on the surface of the cells.

Diseases, Conditions, Syndromes

Stressed-out parasites: Overcoming drug-resistant malaria

Drug resistance to the critical antimalarial therapeutics of the artemisinin family has emerged in Southeast Asia, highlighting the need to understand how these drugs work and how they can be used more effectively. Research ...

page 3 from 10